摘要
目的:研究重症急性胰腺炎(severe acute pancreatitis,SAP)合并急性肾损伤(acute kidney injury,AKI)患者血清沉默信息调节因子1(silent information regulator 1,SIRT1)、蛋白聚糖-1(Syndecan-1)水平变化对患者病情和临床转归的预测能力。方法:前瞻性选取2021年2月—2023年2月临沂市中心医院收治的130例SAP合并AKI患者,另选取同期于我院体检健康的70例健康志愿者。比较健康志愿者与不同AKI分期SAP患者血清SIRT1、Syndecan-1水平。SAP合并AKI患者均接受综合治疗,根据入院28 d临床转归结局将其分为死亡组和生存组,比较两组基线资料。多因素logistic回归模型分析影响SAP合并AKI患者死亡的危险因素。受试者工作特征(receiver operating characteristic curve,ROC)曲线分析血清SIRT1、Syndecan-1对SAP合并AKI患者死亡的预测价值。结果:SAP合并AKI患者血清Syndecan-1水平高于健康志愿者,血清SIRT1水平低于健康志愿者(P<0.05),且随着AKI分期的增加,血清SIRT1水平降低(r=-0.624,P<0.05)、Syndecan-1水平升高(r=0.498,P<0.05)。SAP合并AKI患者入院28 d内死亡率约为24.62%(32/130);与生存组比较,死亡组急性生理与慢性健康(acute physiology and chronic health evaluation,APACHEⅡ)评分、连续肾脏替代疗法治疗比例、血肌酐、尿素氮、D-二聚体(D-Dimer,D-D)、肾损伤分子1(kidney injury molecule 1,KIM-1)、Syndecan-1水平升高,SIRT1水平降低,组间比较差异有统计学意义(P<0.05)。多因素logistic回归分析结果显示:APACHEⅡ评分、血肌酐、D-D、KIM-1、Syndecan-1水平升高,SIRT1水平降低是影响SAP合并AKI患者死亡的危险因素(P<0.05)。ROC曲线结果显示,血清SIRT1、Syndecan-1及其联合应用模型预测SAP合并AKI患者死亡的AUC(95%CI)分别为0.803(0.634~0.948)、0.827(0.702~0.929)、0.857(0.768~0.939)。结论:SAP患者AKI损伤越严重,其血清SIRT1水平越低、Syndecan-1水平越高,且血清SIRT1、Syndecan-1联合检测预测SAP合并AKI患者死
Objective To investigate the predictive ability of changes in serum silencing information regulator 1(SIRT1)and proteoglycan-1(Syndecan-1)levels in patients with severe acute pancreatitis(SAP)complicated with acute kidney injury(AKI)on the patients'condition and clinical regression.Methods A total of 130 patients with SAP combined with AKI admitted to Linyi Central Hospital from February 2021 to February 2023 were prospectively selected,and 70 healthy volunteers who underwent physical examination in our hospital during the same period were also selected.The serum SIRT1 and Syndecan-1 levels were compared between volunteers and patients with SAP with different AKI stages.All patients with SAP complicated with AKI received comprehensive treatment,and they were divided into death group and survival group according to the clinical outcome 28 d after admission,and the baseline data of the two groups were compared.Multivariate logistic regression model was used to analyze the risk factors of death in patients with SAP complicated with AKI.The predictive value of serum SIRT1 and Syndecan-1 for death in patients with SAP complicated with AKI was analyzed by receiver operating characteristic(ROC)curve.Results The serum Syndecan-1 level in patients with SAP complicated with AKI were higher than that of healthy volunteers,and the serum SIRT1 level were lower than that of healthy volunteers(P<0.05),and with the increase of AKI stage,the serum SIRT1 levels were decreased(r=-0.624,P<0.05)and the Syndecan-1 level were increased(r=0.498,P<0.05).The mortality rate of patients with SAP complicated with AKI within 28 d after admission were 24.62%(32/130).Compared with survival group,acute physiology and chronic health evaluation(APACHEⅡ)score,proportion of continuous renal replacement therapy treatment,serum creatinine,urea nitrogen,D-dimer(D-D),kidney injury molecule 1(KIM-1)and Syndecan-1 levels in death group were increased,and SIRT1 levels were decreased,the differences between groups were statistically significant(P<0.05).Mu
作者
李振翮
王贵霞
甄国栋
刘加强
LI Zhenhe;WANG Guixia;ZHEN Guodong;LIU Jiaqiang(Department of Emergency,Linyi Central Hospital,Linyi,Shandong,276400,China;Hemodialysis Room,Linyi Central Hospital)
出处
《临床急诊杂志》
CAS
2024年第1期32-37,共6页
Journal of Clinical Emergency
基金
2020年度山东省医药卫生科技发展计划项目(No:202014051323)。
关键词
重症急性胰腺炎
急性肾损伤
病情
沉默信息调节因子1
蛋白聚糖-1
临床转归
severe acute pancreatitis
acute kidney injury
disease condition
silent information regulator 1
syndecan-1
clinical outcome
